BESILESOMAB
UNII 538316W9ZU

Substance Identification & Data

This profile provides standardized clinical and technical data for Besilesomab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 538316W9ZU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 537694-98-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
538316W9ZU
CAS Registry Number
537694-98-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BESILESOMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C166809
National Cancer Institute reference terminology for clinical and research data.
INN ID
8451
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Besilesomab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BESILESOMAB

Common Names & Synonyms

BESILESOMAB [EMA EPAR]
BESILESOMAB [INN]
BESILESOMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN CEA (CARCINOEMBRYONIC ANTIGEN)-RELATED ANTIGEN) (MOUSE MONOCLONAL BW 250/183 HEAVY CHAIN), DISULFIDE WITH MOUSE MONOCLONAL BW 250/183 .KAPPA.-CHAIN, DIMER

Technical Codes

BW250/183

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus